Safety and Effectiveness of Low‐Density Lipoprotein Cholesterol–Lowering Therapy with Evolocumab for Familial Hypercholesterolemia/Hypercholesterolemia in Japan: A Real‐World, Postmarketing, Single‐Arm Study

Koutaro Yokote, Junya Ako,Kazuo Kitagawa, Nobuhiro Osada, Feng Sheng, Masae Sonoda,Tamio Teramoto

Journal of the American Heart Association（2024）

引用 0|浏览0

暂无评分

关键词

adverse event,evolocumab,familial hypercholesterolemia,hypercholesterolemia,LDL‐C–lowering therapy

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要